Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
These documents saved my life. But it’s also about all who gather on the internet searching for factual information.
The front-runner coronavirus vaccine appears to protect people from symptomatic disease.
Now more than ever learn why the annual flu shot is important while you are dealing with hepatitis C and liver disease.
The vaccine demonstrated 95% efficacy in an ongoing Phase III trial.
Vaccine development is proceeding at an unprecedented pace, but could still hit snags on the way to approval.
The antiviral drug is the first treatment for the new coronavirus to be approved in United States.
These three respiratory illnesses share many of the same symptoms.
The COVID-19 pandemic has turned virtual health from a niche service into a mainstay of modern medicine. But it’s not working for everyone.
The study asks whether certain approved therapies or late-stage investigational drugs show promise against COVID-19.
The Healthcare Anchor Network declares it is undeniable.
The HIV protease inhibitor combination did not speed recovery or reduce the risk of death in a large study.
The trial is evaluating an investigational vaccine from Janssen that may require only one shot.
People with an opioid use disorder, in particular, had a tenfold higher risk of being diagnosed with COVID-19.
FDA weighs whether to resume coronavirus vaccine trial halted due to an adverse event.
A study underway of 300 adults hopes to answer that question within six months to one year.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.